Yang Maya Moaddab, H. R. Palmer, K. Putney; St. Luke’s Episcopal Hosp., Houston, TX. L. L. Rocha

203 WEDNESDAY SCIENTIFIC SESSIONS Final Program ------------------------------------------------------------------------ 253 K Poster Session Ventilator- Associated Pneumonia Wednesday, 9:15 a.m.–11:15 a.m. . . . . . . . . . . . . . . . . Halls A-C Presentations: K-2099 Meta-Analysis of Linezolid vs. Glycopeptide for Treatment of Proven Methicillin-Resistant Staphylococcus aureus MRSA Nosocomial Pneumonia NP Withdrawn K-2100 Comparative Patterns of Drug Regimens in Antipsychotic- Receiving Geriatric Patients with Nosocomial Pneumonia

J. Westphal

1 , F. Jehl 2 , C. Nonnenmacher 3 ; 1 Regional Agency for Hlth., Paris, France, 2 Univ. Lab. for Microbiol., Strasbourg, France, 3 Hosp. Ctr., Strasbourg-Brumath, France. K-2101 The Systematic Application of Intermitent Aspiration of Subglottic Secretions IASS in a Major Heart Surgery MHS- Intensive Care Unit is Feasible and Cost-Effective

M. Perez Granda; Hosp. Gral Univ. Gregorio Marañon, Madrid, Spain.

------------------------------------------------------------------------ 254 L1 Poster Session Bone and Joint Infections Wednesday, 9:15 a.m.–11:15 a.m. . . . . . . . . . . . . . . . . Halls A-C Presentations: L1-2102 Streptococcal Vertebral Osteomyelitis SVO: Multiple Faces for the Same Disease

O. Murillo

1 , A. Roset 1 , B. Sobrino 2 , J. Lora 1 , R. Verdaguer 1 , E. Jimenez- Mejias 3 , J. Nolla 1 , J. Colmenero 2 , J. Ariza 1 ; 1 Hosp. Bellvitge, Barcelona, Spain, 2 Hosp. Carlos Haya, Malaga, Spain, 3 Hosp. Virgen Rocio, Sevilla, Spain. L1-2103 Which Duration of Decubitus in Vertebral Osteomyelitis? G. Gras 1 , D. Mulleman 1 , H. Harrabi 1 , K. Fevre 1 , M. Dupon 2 , B. Mar- chou 3 , C. Marcelli 4 , L. Bernard 1 ; 1 CHRU de Tours, Tours, France, 2 CHU de Bordeaux, Bordeaux, France, 3 CHU de Toulouse, Toulouse, France, 4 CHU de Caen, Caen, France. L1-2104 Vertebral Osteomyelitis Without Bacteremia: How to Ob- tain Microbiological Diagnosis? R. Buzele 1 , G. Gras 1 , J. J. Parienti 2 , F. Debiais 3 , A. Dinh 4 , C. Marcelli 2 , M. Dupon 5 , F. Roblot 3 , L. Bernard 1 ; 1 CHRU de Tours, Tours, France, 2 CHU de Caen, Caen, France, 3 CHU de Poitiers, Poitiers, France, 4 AP-HP, Garches, France, 5 CHU de Bordeaux, Bordeaux, France. L1-2105 Daptomycin Versus Comparator for Treatment of Prosthetic Joint Infection PJI: Prevalence and Susceptibility of Infecting Staphylococci G. M. Thorne, S. Rege, S. Yankelev, C. Gupta, D. Anastasiou, J. Steenbergen, E. Campanaro; Cubist Pharmaceuticals, Lexington, MA. L1-2106 Efficacy of Clindamycin in Combination with Rifampin or Fluoroquinolones for Therapy in Staphylococcal Osteoarticular Infections C. Saroufim, Y. El-Samad, F. Brazier., B. Brunschweiler, B. Canarelli, Y. Douadi, JP Lanoix. E. Justinien, JL Schmit; Amiens Univ. Hosp., Amiens, France. ------------------------------------------------------------------------ 255L2 Poster Session Urinary Tract Infection Wednesday, 9:15 a.m.–11:15 a.m. . . . . . . . . . . . . . . . . Halls A-C Presentations: L2-2107 Surveillance of Antimicrobial Susceptibility of Aerobic and Facultative Gram-Negative Bacilli Isolated from Patients with Urinary-Tract Infections in China: The 2010-2011 Study for Monitoring Antimicrobial Resistance Trends SMART

Q. Yang

1 , H. Zhang 1 , Y. Wang 1 , M. Chen 1 , R. E. Badal 2 , Y. Xu 1 ; 1 Peking Union Med. Coll. Hosp., Beijing, China, 2 Intl. Hlth. Management Associ- ates, Schaumburg, IL. L2-2108 Prevalence and Risk Factors RF of Extended-Spectrum ơ-Lactamases ESBLs Producing E. coli EC in Community Onset CO Urinary Tract Infections UTI J. J. Maya 1 , A. Correa 1 , R. Pacheco 1 , V. M. Blanco 1 , H. Vargas 2 , A. Y. Celis 2 , C. M. Montoya 3 , M. Garzón 3 , F. Rosso 4 , L. Matta 5 , M. E. Vallejo 1,6 , M. V. Villegas 1 ; 1 CIDEIM, Cali, Colombia, 2 Secret. Distr. Salud, Bogotá, Colombia, 3 H. El Tunal, Bogotá, Colombia, 4 Fund. Clin. Valle del Lili, Cali, Colombia, 5 Corp. Comfenalco Valle – Univ. Libre., Cali, Colombia, 6 Univ. Pontificia Bolivariana, Medellín, Colombia. L2-2109 Hospital Epidemiology of Urinary Tract InfectionsColoni- zations Due to ESBL-Producing Escherichia coli R. Lepeule, V. Leflon, D. Vanjak, J. R. Zahar, M. Lafaurie, C. Besson, A. Lefort; Groupe des Référents en Infectiologie d’Ile de France GRIF, Paris, France. L2-2110 Risk Factors of Bacteremia in Urinary Tract Infections A. Lalueza, N. Bermejo, R. García, O. Jiménez, B. Ponce, S. Bermejo, F. López-Medrano, A. G-Reyne, J. Aguado; Hosp. Madrid, Spain. L2-2111 Standardized, Low-Dose Daptomycin is Effective for the Treatment of Urinary Tract Infections

M. Moaddab, H. R. Palmer, K. Putney; St. Luke’s Episcopal Hosp., Houston, TX.

L2-2112 A Micro-Patterned Surface Reduces Microbial Colonization Associated with Catheter-Associated Urinary Tract Infection Withdrawn L2-2113 Increased ESBL Prevalence with Time in Escherichia coli and Klebsiella spp from 50.000 Samples from the Community of a Large City as a Function of Age, Sex, and Location

J. L. L. Rocha

1,2 , F. F. Tuon 3 , J. R. Johnson 4 ; 1 Frischmann AisengartDASA Med. Diagnóstica, Curitiba, Brazil, 2 Hosp. VITA, Curitiba, Brazil, 3 Hosp. Univ. Evangélico, Curitiba, Brazil, 4 VA Med. Ctr. and Univ. of Minnesota, Minneapolis, MN. 204 SCIENTIFIC SESSIONS September 9-12 | L2-2114 Prospective Study of Asymptomatic Bacteriuria in Female Patients with Autoimmune Rheumatic Diseases S. Georgiadou, M. Gamaletsou, I. Mpanaka, A. Vlachou, V. Syriou, G. Kaltsas, M. Tektonidou, M. Manoussakis, N. Sipsas; Natl. and Kapodistrian Univ. of Athens, Athens, Greece. L2-2115 Economic Evaluation of Ceftibuten in the Treatment of Uncomplicated Infection of Urinary Tract in Mexico

M. V. Blandon